RankAlpha logo
Back to Rankings

RARE

Ultragenyx PharmaceuticalC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RARE vs peer average
52/100
RARE vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 4 · D 4
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

BMRN is the first available peer comparator.

BioMarin: established rare-disease commercial and gene-therapy experience; useful comparator.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBMRNBioMarin Pharmaceutical
RARE
Ultragenyx Pharmaceutical
BMRN
BioMarin Pharmaceutical
Grade
C
C
Momentum
83
36
Value
41
65
Sentiment
39
47
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs BMRN

RARE / BMRN
Grade Position
In line
RARE vs. peer average (C vs. C)
52/100
Momentum
83
RARE
Value
41
BMRN
Sentiment
39
BMRN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RARE
1
BMRN
BMRN
C
60/100
Even
2
FOLD
FOLD
-
-
-
3
RGNX
RGNX
A
100/100
-2
4
SUPN
Supernus Pharmaceuticals Inc Common
B
80/100
-1
5
CLDX
Celldex Therapeutics Inc Common
C
60/100
Even
BMRN is the first peer returned for this comparison set.